T细胞免疫球蛋白黏蛋白分子3 与抗肿瘤免疫.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 1022, doi. 10.3872/j.issn.1007-385x.2024.10.012
- By:
- Publication type:
- Article
Works matching IS 1007385X AND DT 2024 AND VI 31 AND IP 10
Results: 14
1
2
CDH3 在恶性肿瘤中的作用及其机制和临床应用的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 1017, doi. 10.3872/j.issn.1007-385x.2024.10.011
- By:
- Publication type:
- Article
3
ATG5 和PDIA3 在宫颈癌组织中的表达及其临床意义.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 1008, doi. 10.3872/j.issn.1007-385x.2024.10.010
- By:
- Publication type:
- Article
4
CHI3L2 在脑胶质瘤中的表达和生物学过程及其对患者临床预后的影响.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 997, doi. 10.3872/j.issn.1007-385x.2024.10.009
- By:
- Publication type:
- Article
5
紫草素联合肿瘤细胞裂解物刺激DC疫苗的抗肿瘤效果.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 957, doi. 10.3872/j.issn.1007-385x.2024.10.003
- By:
- Publication type:
- Article
6
化脓性汗腺炎继发皮肤鳞状细胞癌新辅助治疗后完整切除1 例报告及文 献复习
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 1035, doi. 10.3872/j.issn.1007-385x.2024.10.014
- By:
- Publication type:
- Article
7
瑞舒伐他汀在肿瘤治疗中的应用及其作用机制研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 1029, doi. 10.3872/j.issn.1007-385x.2024.10.013
- By:
- Publication type:
- Article
8
FHL2 与LDHA相互作用促进胶质瘤细胞的增殖.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 976, doi. 10.3872/j.issn.1007-385x.2024.10.006
- By:
- Publication type:
- Article
9
泛素特异性蛋白酶21 对胆管癌细胞增殖及迁移的影响及机制.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 984, doi. 10.3872/j.issn.1007-385x.2024.10.007
- By:
- Publication type:
- Article
10
敲降CD36 抑制白血病细胞培养上清液介导的血小板活化.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 991, doi. 10.3872/j.issn.1007-385x.2024.10.008
- By:
- Publication type:
- Article
11
小鼠结肠癌新抗原Glud1-V546I 及其DC疫苗能够在体内和体外诱导有 效的抗肿瘤免疫应答
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 963, doi. 10.3872/j.issn.1007-385x.2024.10.004
- By:
- Publication type:
- Article
12
DC-CIK不同输注方式治疗原发性肝癌的临床疗效和预后.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 970, doi. 10.3872/j.issn.1007-385x.2024.10.005
- By:
- Publication type:
- Article
13
IL-7 的诱导表达增强靶向GPC3 CAR-T细胞的增殖及体外抗肿瘤活性.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 951, doi. 10.3872/j.issn.1007-385x.2024.10.002
- By:
- Publication type:
- Article
14
细胞治疗产品中关键原材料风险控制策略的审评考虑.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 10, p. 943, doi. 10.3872/j.issn.1007-385x.2024.10.001
- By:
- Publication type:
- Article